1. ILLUMINATE investigators: effects of torcetrapib in patients at high risk for coronary events;Barter;N. Engl. J. Med.,2007
2. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol;Brousseau;N. Engl. J. Med.,2004
3. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease;Brown;N. Engl. J. Med.,2001
4. Smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 2000–2004;Centers for Disease Control and Prevention;Morb. Mort. Wkly. Rep.,2008
5. Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels;Davidson;J. Am. Coll. Cardiol.,2006